Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stock Watch: Will Static Pricing And Rising Inflation Compress Pharmaceutical Margins?

Inflation Should Impact At Least Generic Pharmaceutical Margins First

Executive Summary

Generic pharmaceutical margins are notoriously thin while pricing is limited by intense competition. What happens to margins when raw material and energy pressures rise?

You may also be interested in...



Stock Watch: Why Novartis’s Q3 Misses Matter

Novartis’s use of the phrase “incident population” should have sent shock waves through companies developing gene and cellular therapies. Instead, like the stock price reaction to its lower revenues, the response was demure.

EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group

Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. It warns that inflation and energy costs threaten European drug makers with closures and rationing.

Medicare Part D Price Inflation Rebates Won’t Mean As Much In Inflationary Times

Fewer rebate penalties than lawmakers expected may be assessed in the coming year because of the current high rate of general inflation.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC147175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel